Background: Surgical removal of complicated liver tumors may be realized in two stages via selective portal vein ligation, inducing the atrophy of portally ligated lobes and the compensatory hypertrophy of nonligated liver lobes. Unlike morphological changes, functional aspects such as hepatic cytochrome P450 (CYP)-mediated drug metabolism remain vaguely understood, despite its critical role in both drug biotransformation and hepatic functional analysis. Our goal was the multilevel characterization of hepatic CYP-mediated drug metabolism after portal vein ligation in the rat. Methods: Male Wistar rats (n = 24, 210-230 g) were analyzed either untreated (controls; n = 4) or 24/48/72/168/336 h (n = 4 each) following portal vein ligation affecting approximately 80% of the liver parenchyma. Besides the weights of ligated and nonligated lobes, pentobarbital (30 mg/kg)-induced sleeping time, CYP1A(2), CYP-2B(1/2), CYP2C(6/11/13), CYP3A(1) enzyme activities, and corresponding isoform mRNA expressions, as well as CYP3A1 protein expression were determined by in vivo sleeping test, CYP isoform-selective assays, polymerase chain reaction, and immunohistochemistry, respectively. Results: Portal vein ligation triggered atrophy in ligated lobes and hypertrophy nonligated lobes. Sleeping time was transiently elevated (p = 0.0451). After an initial rise, CYP1A, CYP2B, and CYP3A enzyme activities dropped until 72 h, followed by a potent increase only in the nonligated lobes, paralleled by an early (24-48 h) transcriptional activation only in nonligated lobes. CYP2C enzyme activities and mRNA levels were bilaterally rapidly decreased, showing a late reconvergence only in nonligated lobes. CYP3A1 immunohistochemistry indicated substantial differences in positivity in the early period. Conclusions: Beyond the atrophy-hypertrophy complex, portal vein ligation generated a transient suppression of global and regional drug metabolism, re-established by an adaptive, CYP isoform-dependent transcriptional response of the nonligated lobes.
Introduction
Liver malignancies remain a major medical problem, being the sixth most frequent tumorous disease worldwide as well as the second most common in cancer-related deaths [1] . The first-choice treatment is surgical resection to achieve complete tumor removal [2] ; however, this is only performable in 10-30% of patients, largely due to an insufficient amount of the future liver remnant [2, 3] , and an associated increase in liver failure-related morbidity and mortality [4] . For the treatment of patients with low future liver remnant, portal vein occlusive (PVO) strategies may provide an option [2] . Accordingly, surgical ligation (portal vein ligation; PVL) [5] or embolization of portal vein branches of the tumorous lobes (portal vein embolization) [6] induce the atrophy of tumor-bearing segments and a compensatory hypertrophy of the contralateral -(presumably) healthy liver -to ultimately enable liver resection in a second stage [7] . Optimal timing is crucial for the Scylla and Charybdis scenario of premature resection-induced hepatic dysfunction and imminent tumor progression [7] . Currently, the date of resection is determined using CT volumetry involving the preoperative delineation of the future liver remnant, with consensus threshold values being 25-30% and 40-50% of the tumor-free total liver volume, in healthy or compromised parenchyma, respectively [2] [3] [4] 7] . However, recent findings pointed out that liver volume may inaccurately reflect liver function, only to highlight the special importance of hepatic functional analysis [8, 9] . Many of the vast variety of established liver function tests rely on the quantification of hepatic capacity to convert previously administered chemicals, which dominantly depends on the cytochrome P450 (CYP) enzymes of hepatic drug metabolism [4, 9] . CYPs are a superfamily of heme-thiolate monooxygenases, located in the smooth endoplasmic reticulum of liver cells and many extrahepatic tissues (e.g., intestine, kidney, lung, and brain) and are classified into families and subfamilies according to similarities in their amino acid sequence [10, 11] . CYPs play a central role in the metabolism of a large variety of exogenous and endogenous compounds, and catalyze the phase I oxidative reactions of many drugs, nutrients, environmental pollutants, and endogenous substances (steroid hormones, prostaglandins, bile, and fatty acids) [11] , with CYP 1, 2, and 3 families responsible for the biotransformation of drugs [12, 13] . While CYPs generally possess wide substrate specificity, their activity is influenced by both genetic and nongenetic factors (nutrition, comedication, age, hormonal status, liver function), resulting in substantial intra-and interindividual differences in drug metabolism [14, 15] . Beyond these, CYP expressions and activities are also influenced by different pathophysiological conditions, such as infection, inflammation, cancer, or even PVO [16, 17] . Therefore, any alterations in drug metabolism are critically important during PVO procedures. For the core significance in liver function and functional analysis, drug metabolism confers key information on functional changes following PVO. Moreover, changes in CYP levels or activities may well result in severe derailment of chronic drug regimens, potentially culminating in undesired side effects or therapeutic failures [13] , whereas profiling of CYP expressions and activities may reflect on hepatic drug metabolism [18] . New insights could lead to not only an improved knowledge in liver function testing and the better itineration of resection, but also an enhanced utilization and personalization of perioperative drug doses.
Consequently, the aim of our study was the investigation of the transient changes of functional alterations in CYP-mediated drug metabolism following PVL in an experimental rat model involving healthy liver parenchyma.
Materials and Methods

Animals
Experimental design was harmonized with the guidelines of the National Institutes of Health and the 40/2013 (II.14) Act of the Hungarian Government concerning animal experiments, as well as actual ARRIVE guidelines [19] . Male Wistar rats, aged 7 weeks, weighing 210-230 g (Central Animal Facility, Semmelweis University, Budapest, Hungary) were used in the experiment.
Experimental Design and Surgical Procedure
Following the induction of general anesthesia (intraperitoneal [i.p.] injection of 75 mg/body weight [bw] kg ketamine and 7.5 mg/bw kg xylazine in 1.5 mL saline), rats underwent median laparotomy and PVL affecting approximately 80% of the total liver parenchyma (n = 20), as previously described by our workgroup [20, 21] . After abdominal saline lavage, antibiotic (10 mg/bw kg metronidazol i.p.) and postoperative analgesic (1 mg/bw kg nalbuphine subcutaneously, repeated once 24 h later) treatment and double-layered abdominal suturing, the rats were allowed to rest in their cages. Following different postoperative survival times of 24/48/72/168/336 h, the rats (n = 4 each), as well as another group of rats spared the operative procedure to be used as controls (n = 4), were all subjected to the pentobarbital sleeping test. Its finalization was followed by the repeated, previously described i.p. anesthetic injection to allow sacrificing of the animal with right ventricular exsanguination for the harvest of liver samples (Fig. 1) .
Pentobarbital Sleeping Test
The pentobarbital-induced sleeping time was measured to evaluate in vivo hepatic CYP activity after i.p. injection of pentobarbital (30 mg/bw kg in 1 mL saline). The resting rat was placed lying on its back, and the start of the pentobarbital-induced sleep was defined as the moment when the instinctive reaction of the rat of turning to one side (referred to as the "righting reflex") was completely lost, whereas the end was determined by the spontaneous reappearance of the righting reflex, with the total sleeping interval specified as the "sleeping time" [22] .
Liver Lobe Weights
Secondary to exsanguination, the liver lobes associated with either the ligated (ligated lobes; LL) or intact (nonligated lobes; NLL) portal vein branches were both measured with a laboratory scale (AG245, Mettler Toledo, Columbus, OH, USA; confidence: 0.01 mg/0.1 mg), and their individual as well as combined wet weights (total liver weight) were expressed as per body weight as well as total liver weight.
Preparation of Liver Microsomes and CYP Enzyme Activity Assays
Liver tissues from both the LL and NLL were homogenized in 0.1 M Tris-HCl buffer (pH 7.4) containing 1 mM EDTA and 154 mM KCl (Reanal Finechemicals Co., Budapest, Hungary). Hepatic microsomal fractions were prepared by the method of differential centrifugation [23] and were stored at -80 ° C until further analysis. The protein content of the microsomes was determined by the method of Lowry et al. [24] , with bovine serum albumin as the standard (Sigma-Aldrich GmbH, Deisenhofen, Germany). Subsequently, CYPselective enzyme activities were determined by previously published methods, involving ethoxyresorufin O-deethylation for CYP1As [25] , pentoxyresorufin O-dealkylation for CYP2Bs [25] , tolbutamide 4-hydroxylation for CYP2Cs [26] , and midazolam 1′-and 4-hydroxylation for CYP3As, respectively [27] . The incubation mixture contained an NADPH-generating system (1 mM NADPH, 10 mM glucose 6-phosphate, 5 mM MgCl 2 , and 2 IU/mL glucose 6-phosphate dehydrogenase), rat liver microsomes, and the respective CYP isoformspecific substrate (ethoxyresorufin, pentoxyresorufin, tolbutamide, or midazolam for CYP1As, CYP2Bs, CYP2Cs, and CYP3As, respectively). Enzyme reactions were terminated by either ice-cold methanol or acetonitrile. High-performance liquid chromatographic analyses were performed while adhering to published methods [26, 27] . The fluorescence of resorufin was quantified at 550 nm excitation and at 589 nm emission wavelengths [25] . Finally, beyond the determination of "intrinsic" microsomal CYP isoform activities, expressed as [pmol metabolite/(mg microsomal protein × min)], the total CYP isoform activities of the LL and the NLL were also extrapolated after scaling with the corresponding weights of the LL or NLL, and displayed in relative units (% of control).
RNA Isolation and Quantitative RT-PCR
Total RNA was isolated from the liver samples (TRI reagent, Molecular Research Center Inc., Cincinnati, OH, USA) according to the manufacturer's instructions. The purity and the concentration of the RNA samples were determined spectrophotometrically (NanoDrop 1000, Thermo Fisher Scientific Inc., Waltham, MA, USA). RNA (3 µg) was reverse-transcribed into single-stranded cDNA (Maxima First Strand cDNA Synthesis Kit, Thermo Fisher Scientific Inc.), and RT-PCR was performed (Maxima SYBR Green qPCR Master Mix, Thermo Fisher Scientific Inc.) using the respective primers for CYP isoforms: CYP1A2, CYP2B1, CYP2B2, CYP3A1, CYP2C6, CYP2C11, CYP2C13 ( Table 1 ). The quantity of the target mRNA relative to that of the housekeeping gene hypoxanthine phosphoribosyltransferase (HPRT) was determined [28] . 
Histopathological Analysis
Liver samples were excised from identical anatomical parts of the LL and the NLL, fixed in 4% neutralbuffered formaldehyde, and embedded in paraffin. Sections of 3-5 µm were cut, deparaffinized (EZ Prep 10×, F. Hoffmann-La Roche, Basel, Switzerland) and rehydrated. Antigen retrieval was performed for 30 min with a prediluted solution (Cell Conditioning 1, Ventana Medical Systems, F. Hoffmann-La Roche) designated for automated immunohistochemical slide stainers. A standard immunohistochemical reaction was performed in an automated immunohistochemical reaction slide staining system (BenchMark ULTRA, Ventana Medical Systems, F. Hoffmann-La Roche) with a respective detection kit (ultraView Universal DAB Detection Kit, F. Hoffmann-La Roche) involving a standard horseradish peroxidase-diaminobenzidine reaction. Rabbit polyclonal primary antibodies against CYP3A1 (BML-CR3310-0025; Enzo Life Sciences Inc., Farmingdale, NY, USA) were applied at 42 ° C for 32 min in a dilution of 1: 1,000. The manufacturer's instructions were always followed. Sections were counterstained with hematoxylin and scanned to produce digital material.
Statistical Analysis
Data are expressed as the mean ± standard deviation. Statistical analysis of parametric data involved the analysis of variance (ANOVA) test with Bonferroni's post hoc test. Statistical significance was declared in the case of p values ≤0.05. GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA, USA) was used for analyses and visualization.
Results
Pentobarbital Sleeping Test
Sleeping time gradually increased after PVL with a significantly elevated peak at 72 h (p = 0.0451), and thereafter normalized to control levels ( Fig. 2) . However, sleep latency (the time for complete loss of righting reflex after pentobarbital injection) at each time point was similar to that of the control group (data not shown). 
Liver Lobe Weights
Following PVL, the weight of the LL, constituting 76 ± 1.83% of total liver weight and 3.77 ± 0.27% of body weight in controls, progressively decreased to only 15.25 ± 7.18% of total liver weight and 0.63 ± 0.33% of body weight by 336 h (p < 0.0001). Meanwhile, NLL weights significantly increased from the control values of 23.25 ± 1.71% of total liver weight and 1.17 ± 0.05% of body weight to 84.25 ± 6.4% of total liver weight and 3.37 ± 0.29% of body weight by the end of the experiment (p < 0.0001). A slight but significant decrease in total liver weight was observed 24 h after PVL; however, total liver weight remained essentially unchanged thereafter (Fig. 3) .
In vitro CYP Enzyme Activity Assays
The "intrinsic" microsomal CYP activities [pmol/mg protein × min] were assessed initially (Fig. 4-7) . Enzyme activities of CYP1A and CYP3A (measured both by midazolam 1′-and 4-hydroxylation) displayed very similar characteristics (Fig. 4a, 7a, c) . At 24 h after PVL, enzyme activities were significantly increased in the NLL, after which the activities of both lobes gradually decreased until 72 h. Thereafter, however, the enzyme activities diverged. In the NLL, a significant increase in ethoxyresorufin O-deethylation as well as in midazolam 1′-and 4-hydroxylation was observed at 168 h compared to the control values, followed by convergence to baseline by 336 h. Meanwhile, enzyme activities in LL, despite a temporary insignificant gain, exhibited a downward tendency beyond 48 h. Consequently, a discrepancy developed between enzyme activities of LL and NLL, which resulted in a statistically significant difference as early as 24-48 h, and became most prominent at the late time points of 168-336 h. CYP2B enzyme activities showed some similarities to that of CYP1A and CYP3A; however, both the late rise of CYP2B activity in NLL, and concomitantly the discrepancy of LL and NLL activities, were moderate and only tendentious (Fig. 5a ). CYP2C activities displayed completely different features (Fig. 6a) . Tolbutamide 4-hydroxylation activity of both the LL and the NLL underwent a sharp and significant decrease immediately post-PVL. However, after 168-336 h, enzyme activity in the NLL showed a late convergence to the baseline, while the LL remained permanently depressed, which also resulted in a gaping discrepancy and a significant difference of CYP2C enzyme activities between LL and NLL at the late time points of 168-336 h. Changes of total CYP activities extrapolated from "intrinsic" activities by scaling with the weight of LL or NLL were generally very similar to the corresponding "intrinsic" microsomal CYP activities, with matching curve characteristics (Fig. 4b , 5b, 6b, 7b, d). However, the "up-scaling" with LL and NLL weights further amplified the results observed in terms of "intrinsic" microsomal activities primarily in the later stages. Thereby, while the lowered activity of the LL further sank, the progressively increased activity of the NLL became more prominent due to the shift of lobe weights, resulting in significantly elevated total NLL CYP1A, CYP2C, and CYP3A function even at 336 h, as well as a greater interlobar discrepancy, also in terms of CYP2B. Subsequent to the surge in total CYP activity of the NLL, the combined total CYP1A and CYP3A activities of the liver were also significantly elevated at 168 h compared to control values. The redistribution of total liver CYP function was observable in terms of all isoforms, reflected in a rise from the 28 ± 2% control functional contribution of the NLL to the total extrapolated CYP function of the liver to 96 ± 2% by 336 h (p < 0.0001).
Transcriptional Expression of CYP Enzymes
The mRNA levels of CYP2B1, CYP2B2, and CYP3A1 reflected generally similar changes (Fig. 5c, d, 7e) . Here, mRNA levels of the NLL showed an early, steep, and significant increase in the 24-to 48-h period, followed by a rapid redistribution to baseline levels. Meanwhile, mRNA levels in the LL showed either only a modest increment (CYP2B1 and CYP2B2) or were unchanged (CYP3A1). Hence, a significant difference was verified between LL and NLL mRNA expression levels, confined to the early postoperative period of 24-48 h, peaking at 48 h. While a gap of LL and NLL mRNA expression levels was also present in the case of CYP1A2 (Fig. 4c) , instead of only an early localization, it was observable throughout the whole post- operative period from 24 to 336 h, which was generated by a dramatic, immediate, and definite reduction of CYP1A2 mRNA expression in the LL, in parallel to an upheld (and at 48 h, tendentiously increased) mRNA expression of the NLL. Again, CYP2C6, CYP2C11, CYP2C13 mRNA concentrations displayed different characteristics (Fig. 6c-e) . While the mRNA levels of the LL were always significantly and permanently depressed, CYP2C mRNA expression in the NLL was either maintained (CYP2C6), or showed only a temporary decrement with later reconvergence either bordering (CYP2C13) or even reaching the baseline levels (CYP2C11).
As a result, a significantly higher mRNA expression in the NLL was once again displayed dominantly in the later stages of 168-336 h, but was also present at 48 h in terms of CYP2C6 and CYP2C13. 
Histopathological Analysis of CYP3A1 Protein
Representative images of the CYP3A1 immunohistochemical reaction are shown at various termination timepoints (Fig. 8) . CYP3A1 positivity of the LL decreased after PVL and remained permanently lower. While positivity in the NLL was also lower as compared to controls at 168 h, a maintained expression between 24 and 72 h resulted in a difference of CYP3A1 positivity between LL and NLL in the early postoperative period.
Discussion
Future liver remnant enlargement via PVO remains the sole curative option for a wide range of patients with liver malignancies [3, 7, 29] . During the induced liver regeneration process, the precise alterations of hepatic drug metabolism are still incompletely understood, despite its key role in both hepatic function and the metabolism of endogenous and exogenous compounds [30] . Our primary objective was the temporal and regional, multilevel characterization of hepatic drug metabolism and its inherent CYP enzymes during PVLinduced liver regeneration in the rat. The present study found an early, transient deterioration of the global drug metabolizing capacity, which was echoed by the contemporary individual functions of both LL and NLL. We verified a solid, disparate difference between the drug metabolism of the LL and NLL. As a result of an adaptive response of active transcriptional upregulation, drug metabolism in the NLL was increased and re-established, meanwhile permanently depressed in the LL due to the lack of such adaption. Hepatic drug metabolism became overwhelmingly redistributed, depending nearly exclusively on the NLL. Our findings also proved the isoform-dependence of CYP enzyme activity and transcription alterations following PVL in the rat.
PVL induces a chain of events, ultimately culminating in a very special form of liver regeneration [5, 6] . Eventually, the LL undergoes atrophy and underlying necroapoptotic cell death, meanwhile the NLL displays an intensive cellular proliferation and hypertrophy [21, 29] , which was repeatedly proven by the literature [2, 5, 29, 30] and previous reports of our workgroup [20, 21, 31] . In the present study, it was similarly reflected by liver lobe weights, thereby validating the standard application of the PVL model, and allowing further, more sophisticated analysis. Beyond the phenomenon, morphological features following PVO possess key clinical significance, since the timing of stage II resection is consensually determined by CT liver volumetry [2] [3] [4] 7] . However, (posthepatectomy) liver failure is directly dependent on liver function, but not liver volume, and the two may dramatically differ, according to recent reports [8, 9] . Therefore, the significance of functional analysis during PVO procedures is dramatically increasing. A core hepatic function is the ability to convert and eliminate endogenous and exogenous chemical substances, generally referred to as drug metabolism, which directly relies on key CYP enzymes [11] [12] [13] . Besides nongenetic factors, such as age and hormonal status, CYP activities and expressions are influenced by a variety of environmental and acquired factors such as nutrition, comedication, infections, inflammation, and cancer -f, h-l) and controls (a, g) . The reactions were simultaneously processed using identical protocols in an automated slide stainer, with primary antibodies against CYP3A1 and standard labelling based on horseradish peroxidase-diaminobenzidine interaction. On all sections, CYP3A1 protein expression displayed a uniform pericentral localization. [15] , which may either induce their activities through transcriptional upregulation over days, or oppositely, reduce CYP activities through downregulation of transcription or instantaneous posttranslational inactivation [12] . Any changes in CYP enzyme activities could subsequently result in the alterations of drug metabolism, which may lead to adverse drug-related effects of drug intoxication or therapeutic failure [13] . In particular, pathophysiological conditions of the liver, including liver regeneration after partial hepatectomy [32] or PVO [16] , carry the grave danger of reduced hepatic function and CYP activity derangements, which is well reflected in the CYP dependence of several quantitative liver function tests [4] . Therefore, an improved understanding of PVO-induced alterations in hepatic drug metabolism and CYP activities holds great clinical potential for the prevention of drug-related complications and the extension of the available knowledge regarding liver function alterations during induced liver regeneration. In our pursuit of the analysis of drug metabolism after PVL, a proximal element was the pentobarbital sleeping test, representing the CYP-mediated metabolism and elimination of pentobarbital. Herein, the overall CYP activity, as well as global drug metabolism, was temporarily reduced until 72 h after PVL and was retrieved by the end of the second week. In accordance with this, Takemura et al. [30] and Starkel et al. [33] also found a transient reduction in hepatic drug metabolism following PVL. Furthermore, on a larger scale, the transitional deterioration of global liver function after PVO, as confirmed by different functional tests, was described both by our and other previous literature reports [20, 31, 34] . On the other hand, the sleeping test fails to assess the individual functional aspects of the LL and the NLL. Whereas following the first step (i.e., PVO) of two-step liver resections incorporating preoperative liver remnant enlargement by PVO, both the LL and the NLL persist in the body; however, after the interval period and the subsequent second-step resection of the LL, only the NLL is preserved, upon which the metabolic demands of the body rest. Therefore, regional functional analysis, and specifically the assessment of the NLL function is of utmost importance, for which we embarked on the investigation of drug metabolism as well as the expression and activities of underlying CYP isoenzymes individually in the LL and the NLL. With interspecies differences of sequence, substrate specificity, and regulation in mind [12, 13] , several representative, clinically most relevant CYP isoenzymes were chosen from the CYP1, CYP2, and CYP3 families, which are almost exclusively responsible for the metabolism of drugs and other xenobiotics [11] . CYP1A enzymes are known for their great interspecies homology; therefore, they provide good ground for comparison between humans and rats [11, 12] . CYP2B1 and CYP2B2 isoenzymes metabolize anesthetic drugs, and also provide good comparison between humans and rats [11, 12] . The CYP3A subfamily is critically important both in humans and rats, for it metabolizes approximately 40% of drugs on the market. They comprise approximately 30% of CYP content of the human liver, with CYP3A4 as the dominant enzyme. In the rat, CYP3As are also essential, even though they make up a smaller fraction of hepatic CYPs. On the other hand, a number of induction/inhibition differences between human CYP3A4 and its rat correspondent CYP3A1 are known, for which CYP3As provide highly relevant interspecies comparison, with certain limitations [11] [12] [13] . In humans, CYP2Cs are of limited significance, metabolizing only approximately 16% of drugs and constituting just 20% of liver CYP content, whereas in the rat, with over 50%, they are the most abundant CYPs contained in the liver with a correspondingly high metabolic relevance. Finally, rat CYP2Cs show great sexual predominance, with CYP2C11 and CYP2C13 as the most prominent male-specific isoforms, whereas CYP2C6 is sex independent [11] [12] [13] . Consequently, in the present study, CYP1A, CYP2B, CYP2C, and CYP3A enzyme activities, along with CYP1A2, CYP2B1, CYP2B2, CYP2C6, CYP2C11, CYP2C13, and CYP3A1 mRNA levels were measured to better understand alterations in CYP enzyme functions and the underlying transcriptional regulation. The "intrinsic" activities of CYP1A and CYP3A, and to a lesser extent CYP2B, displayed a very similar pattern of an early rise at 24 h, followed by a downward tendency up to 72 h, after which NLL activities were increased before returning to baseline, meanwhile enzyme activities of the LL remained permanently low. Concomitantly, total lobar activities of the same enzymes generally matched that of the "intrinsic" enzyme activities. However, lobe weight-scaling further amplified the discrepancies of the LL and the NLL activities, as well as the potent increase of NLL function at 168-336 h, which also led to an increased total liver activity at 168 h, and a massively raised functional share of the NLL of total liver activity, going from the control 28% to 96% at 336 h. At the mRNA level, sharp contrast was observed between the LL and NLL, with the NLL exhibiting a very early transcriptional upregulation of CYP1A2, CYP2B1, CYP2B2, and CYP3A1 at 24-48 h, which was lacking in the LL. To interpret these, the increase in CYP enzyme function at 24 h is considered to be the consequence of CYP protein stabilization and/or de novo protein synthesis in NLL [12] . Meanwhile, CYP2C results were markedly different. Both "intrinsic" and total lobar activities as well as the mRNA levels of the male-dominant CYP2C11 and CYP2C13 were suddenly sharply reduced in both lobes, and a late reconvalescence of both enzyme functions and mRNA expression to baseline were seen only in the NLL at the late time point of 336 h. CYP2C6 expression was also downregulated in LL; however, it did not display any significant fluctuation in NLL. Perhaps the most striking observation is the dramatic difference of lobar responses, as part of which drug metabolism in the LL was permanently deteriorated, whereas it was re-established in the NLL, which may be explained by the far-reaching effects of PVL. Beyond the seemingly solitary action of portal blood flow stoppage to the LL, PVL induces a chain of events, such as the complete redistribution of the splanchnic circulation (arterialized hypoperfusion of the LL; massive portal hyperperfusion of the NLL) and modification of blood decomposition, by which the NLL receives an increased portion of nutritional agents, growth factors, hormones, and bacterial products [29] . These culminate in the induction of a very special form of liver regeneration characterized by the atrophy-hypertrophy complex [29, 35] , and diverse pathophysiological changes of structural and microvascular remodeling within the LL and the NLL [20, 29] , which may ultimately explain the different functional capacities of the LL and the NLL [31, 35] . The other important finding that should be addressed is the markedly different pattern of changes regarding the CYP2C enzymes as compared to CYP1A, CYP2B, and CYP3A. In the early postoperative period, both lobes exhibited a dramatic reduction in CYP2C enzyme activity as well as transcription, which may be multifactorial. Earlier reports also confirmed a transiently reduced CYP-dependent drug metabolizing capacity after PVL. Takemura et al. [30] concluded a lag of functional (CYP3A2, CYP2C11) to morphological regeneration, whereas Starkel et al. [33] reported CYP3A and CYP2E1 functional deterioration in the very early (0.5-8h) postoperative period secondary to surgical stress but not liver regeneration. Regarding the molecular background of CYP depression, both studies agreed on the central role of inflammatory cytokines (IL-1β, IL-6, TNF-α), as well as the upregulation and increased nitric oxide production of inducible nitric oxide synthase [30, 33] . During different pathophysiological conditions such as infection, inflammation, and cancer, increased levels of circulating proinflammatory cytokines lead to CYP downregulation [17, 36] through the repression of nuclear receptors (pregnane X receptor and constitutive androstane receptor) involved in transcriptional regulation of several CYPs (CYP2B, CYP2C, CYP3A) [37, 38] . Meanwhile, the same cytokines, as well as nitric oxide, also play a central role in the initiation and mediation of liver regeneration after both partial hepatectomy and PVO, when their serum levels are sharply increased secondary to inflammatory activation and hemodynamical changes, respectively [29, 35, 39] . Therefore, it is highly plausible that increased levels of inflammatory cytokines as well as nitric oxide may be partly responsible for the transient deterioration of CYP function following PVL. As compared to these previous reports, our study is the first to investigate the underlying transcriptional regulation through the analyses of corresponding, specific mRNA expressions parallel to the enzyme activities of a wide range of highly relevant CYP enzymes throughout the full duration of PVL-induced liver regeneration. CYP2Cs displayed marked differences in enzyme activity as well as underlying mRNA levels compared to the other subfamilies, both in the early and late phase of regeneration. During the latter, the waning effects of cytokines and nitric oxide could not fully account for the discrepancy of CYP2Cs, whereas a possible explanation might lie in sex hormonedependent regulation. The expression of CYP2C enzymes, and particularly the male-predominant CYP2C11 and CYP2C13 is regulated by the hypothalamus-hypopituitary-gonadal axis and primarily affected by the actual balance of testosterone/estrogen levels [12] . Besides exogenous chemicals, endogenous disease states are also capable of causing reduced CYP expression or function by interfering with sex hormonal levels [12] . Earlier studies reported that pathophysiological states of the liver (including partial hepatectomy, PVL, bile duct ligation) led to the "demascularinization" of drug metabolism (decreased expression of malespecific and increased expression of female-specific enzymes) along with lower serum testosterone and increased (gastric parietal cell-generated) estradiol levels, as well as hypothalamic-hypopituitary-gonadal suppression [16, 32, 40] . Consequently, regarding the present study, an increased presence of female sex hormones may have contributed to the rapid and prolonged decrement of CYP2C enzyme activities and male-specific CYP2C11 and CYP2C13 mRNA expressions, while CYP2C6 expression of the NLL was preserved. In the meantime, the restitution and hyperfunction of sex hormone-independent CYP1A and CYP3A1 activities by 168 h and early steep increase of their respective mRNA expressions could indicate a potent adaptive response of the NLL, perhaps an endogenous "escape" mechanism of the organism to mitigate the functional suppression of CYP2C enzymes. Meanwhile, the LL failed to present such an increment, most likely due to the described severe morphostructural consequences of PVL. Finally, the representative CYP3A1 immunohistochemical reaction also indicated a preserved early postoperative positivity of CYP3A enzymes in the NLL as compared to the progressively diminished positivity of the LL. Overall, the individual drug metabolism of the NLL seems to be re-established, whereas permanently deteriorated in the LL, confirming disparate tendencies of adaption, and a shift of hepatic drug metabolism towards the NLL. These are in accordance with the latest studies of our workgroup, involving complex liver functional analyses following PVL [20, 31] . Concerning clinical significance, the present results may help characterize liver functional changes during two-step liver resections incorporating future liver remnant enlargement via PVO procedures, translating as the enhanced itineration of the second-step resection. Furthermore, an improved knowledge of liver drug metabolism could help prevent drug complications through the adaption of medication dosage to the actual capacities of hepatic CYPs. This brings about the modern concept of personalized medication and patient-tailored drug regimens, such as the estimation of the drug metabolizing capacity based on the genotyping and expressional patterns of CYPs [18] . The current analysis underlined CYP isoform-dependent responses, which take this personalized approach a step further, by suggesting an even more precisely tailored medication strategy. Therein, drug dosage may be weighed against the contemporary activities of the specifically corresponding CYP isoforms. A noteworthy limitation of our study is the utilization of a "healthy liver" model, concerning which our goal was the most direct evaluation of the pathophysiological effects of PVO on hepatic drug metabolism. It is only a partial hindrance, since clinically, tumors often develop in parenchymal disease-free livers. Such is the case of metastases, the most frequent liver tumors worldwide [1] . However, (predominantly primary) liver tumors often manifest in disease-affected liver parenchyma (steatohepatitis, fibrosis, cirrhosis, cholestasis, etc.), which may interfere with CYP expression and hepatic drug metabolism. Supporting this, the Heidelberg workgroup found reduced CYP2E1 expression in liver fibrosis, identified with liver stiffness elastography, as well as boosted CYP expression, drug metabolism, and subsequently increased, carcinogenic etheno-DNA adducts in (nonfibrotic) alcoholic liver disease [41, 42] . Therefore, the in-depth evaluation of CYP regulation in liver disease states is also of chief clinical relevance. Further research is imperative for the complex understanding of the role and individual changes of CYP enzymes following PVO procedures in both the absence and presence of parenchymal liver diseases.
Conclusions
PVO and PVL remain key treatment options of complicated liver tumors, during which functional aspects, such as the elimination of endogenous and exogenous compounds are crucial. Monitoring the alterations in hepatic drug metabolism and underlying CYP enzymes is critically important for a better understanding of post-PVO liver function, as well as for the prevention of drug-related complications. Our study verified a transient suppression of global hepatic function, followed by the adaptive response of NLL and the permanent deterioration of the LL resulting in solid interlobar differences. Furthermore, changes were found to be isoform dependent, with a somewhat different expression and activity profiles of CYP1A, CYP2B, and CYP3A as compared to CYP2C enzymes. Results may contribute to knowledge regarding liver function as well as personalized medication strategies during induced liver regeneration, although further investigation is required.
